Neratinib in Combination With Trastuzumab for the Treatment of Patients With Advanced HER2-positive Breast Cancer: A Phase I/II Study.
| Autor: | Blackwell, Kimberly L., Zaman, Khalil, Qin, Shukui, Tkaczuk, Katherine H.R., Campone, Mario, Hunt, Daniel, Bryce, Richard, Goldstein, Lori J., on behalf of the 202 Study Group, 202 Study Group |
|---|---|
| Zdroj: | Clinical Breast Cancer; Apr2019, Vol. 19 Issue 2, p97-104, 8p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|
Full Text from ScienceDirect